NASDAQ: ZJYLJin Medical International Ltd Stock
$2.39+0.02 (+0.84%)
Updated Jun 16, 2026
ZJYL Price
$2.39
Fair Value Price
-$0.85
Market Cap
$18.71M
52 Week Low
$1.64
52 Week High
$17.18
P/E
11.95x
P/B
0.63x
P/S
4.28x
PEG
N/A
Dividend Yield
N/A
Revenue
$20.69M
Earnings
$1.19M
Gross Margin
29.2%
Operating Margin
6.8%
Profit Margin
5.8%
Debt to Equity
0.8
Operating Cash Flow
$3M
Beta
1.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ZJYL Overview
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ZJYL's potential to beat the market
- ZJYL doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
A
ZJYL
RankedUnranked of 42
RankedUnranked of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.80 | A | |
| $14.99 | B | |
| $22.69 | B |
Be the first to know about important ZJYL news, forecast changes, insider trades & much more!
ZJYL News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZJYL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZJYL ($2.39) is overvalued by 380.02% relative to our estimate of its Fair Value price of -$0.85 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ZJYL ($2.39) is not significantly undervalued (380.02%) relative to our estimate of its Fair Value price of -$0.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ZJYL was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ZJYL due diligence checks available for Premium users.
Valuation
ZJYL fair value
Fair Value of ZJYL stock based on Discounted Cash Flow (DCF)
Price
$2.39
Fair Value
-$0.85
Undervalued by
380.02%
ZJYL ($2.39) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZJYL ($2.39) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZJYL was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ZJYL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.95x
Industry
42.08x
Market
13.25x
ZJYL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ZJYL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ZJYL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.63x
Industry
3.2x
ZJYL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZJYL's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ZJYL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZJYL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$53.4M
Liabilities
$23.8M
Debt to equity
0.8
ZJYL's short-term assets ($44.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZJYL's short-term assets ($44.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZJYL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ZJYL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZJYL vs Medical Stocks
Jin Medical International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.